Baird Medical Investment Holdings Ltd Ordinary Share (BDMD) is a publicly traded Healthcare sector company. As of May 21, 2026, BDMD trades at $1.63 with a market cap of $50.43M and a P/E ratio of 0.00. BDMD moved +0.00% today. Year to date, BDMD is +26.92%; over the trailing twelve months it is -67.33%. Its 52-week range spans $0.76 to $12.50. Rallies surfaces BDMD's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Baird Medical’s 2025 Revenue Falls 39.2% to $22.5M, Names U.S. CEO: Full year 2025 revenue was $22.5 million, down 39.2%, leading to an operating loss of $25.6 million and a gross margin decline to 83.8% from 88.2%. Baird appointed Mark Saxton as U.S. CEO and set up a North American production hub for U.S. expansion.
| Metric | Value |
|---|---|
| Price | $1.63 |
| Market Cap | $50.43M |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $12.50 |
| 52-Week Low | $0.76 |
| Volume | 49 |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
BDMD analyst coverage data. Average price target: $0.00.